Home | Welcome to Contract Pharma   
Last Updated Sunday, September 21 2014
Print

Breaking News

Related Searches:
March 4, 2010
Congenix, a Moscow-based CRO, has become a certified member of Health Decisions’ Agile Clinical Network, a group of research partners formed to help eliminate the information gaps and prolonged timelines for complex global studies.  Read More »
March 4, 2010
Yvonne Verburgt has been named vice president of business development and marketing for Avrio Biopharmaceuticals, LLC.   Read More »
March 3, 2010
First round of major R&D cuts at AstraZeneca includes dropping early research in many fields  Read More »
March 3, 2010
ADC collaboration bears fruit for Genentech with IND  Read More »
March 3, 2010
Lilly gets $1 million, keeps option to reacquire  Read More »
March 3, 2010
Dimebon fails in CONNECTION trial  Read More »
March 3, 2010
BMS, Allergan to co-develop Phase II-ready neuropathic pain compound  Read More »
March 2, 2010
Andreotti to replace Cornelius as CEO  Read More »
March 2, 2010
Walcott named vp quality and compliance  Read More »
March 2, 2010
PPD enters European market with Athlone site  Read More »
March 2, 2010
New appointments as Cytovance expands in international markets  Read More »
March 2, 2010
Asterand adds to PhaseZERO suite of preclinical services  Read More »
March 2, 2010
WuXi and J&JPRD have established a preclinical services and training agreement  Read More »
March 1, 2010
Astellas Pharma has made an unsolicited bid of $3.5 billion in cash to buy all outstanding shares of OSI Pharma.  Read More »
March 1, 2010
AstraZeneca will exercise its option to buy out Merck's interest in AZ's non-PPI products for $647 million.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On